A hypothesis for the in vivo antioxidant action of salicyclic acid

BioMetals

Volumn 9, Issue 3, 1996, Pages 285-290

  Cheng, I Francis ^a   Zhao, Christopher P ^b   Amolins, Andris ^b   Galazka, Malgorzata ^b   Doneski, Leon ^b  

^a University of Arizona   (United States)

^b SETON HALL UNIVERSITY   (United States)

Author keywords

Antioxidant; In vivo; Iron; Mechanism; Salicylic acid

Indexed keywords

DNA; EDETIC ACID; FERROUS GLUCONATE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; SALICYLIC ACID; SCAVENGER; SUPEROXIDE DISMUTASE;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL DAMAGE; CHELATION; CONTROLLED STUDY; DRUG MECHANISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFLAMMATION; OXIDATION; OXIDATION REDUCTION POTENTIAL; OXIDATION REDUCTION REACTION; PH; POTENTIOMETRY; THERMODYNAMICS; THYMUS;

EID: 0030059174     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00817929     Document Type: Article

References (31)

1. Abramson S, Korchak H, Ludewig R, et al. 1985 Modes of action of aspirin-like drugs. Proc Natl Acad Sci USA 82, 7227.
2. Allenthoff AJ, Bolton JL, Wilks A, Thompson JA, de Montellano PRO. 1992 Heterolytic versus homolytic peroxide bond cleavage by sperm whale myoglobin and myoglobin mutants. J Am Chem Soc 114, 9744.
3. Andrews FJ, Morris CJ, Kondratowicz G, Blake DR. 1987 Effect of iron chelation on inflammatory joint disease. Ann Rheum Dis 46, 327.
4. Arouma OI, Halliwell B. 1988 The iron-binding and hydroxyl radical scavenging action of anti-inflammatory drugs. Xenobiotica 18, 459.
5. Bard AJ, Faulkner LR. 1980 Electrochemical Methods. New York: John Wiley; 460.
6. Borne RF. 1986 Nonsteroidal anti-inflammatory agents, antipyretics, and uricosuric agents. In Verderame M, ed. CRC Handbook of Cardiovascular and Anti-inflammatory Agents. Boca Raton, FL: CRC Press; 40.
7. Brun PF, Schrøder KH. 1975 Complexation with salicylic acid, copper(II) and calcium complexes. J Electroanal Chem 66, 9.
8. Crichton RR. 1991 Inorganic Biochemistry of Iron Metabolism. Chichester: Ellis Horwood; 190.
9. Crichton RR, Ward RJ. 1992 Iron metabolism - new perspectives in view. Biochemistry 31, 11255.
10. Dreser H. 1899 Pharmakologisches uber aspirin (Acetyl-salicylsaure). Pflüger Arch 76, 306.
11. Florence TM. 1991 The role of free radicals in cancer and aging. In: Dreosti IR, ed. Trace Elements, Micronutrients and Free Radicals. Totowa, NJ: Humana Press; 171-198.
12. Gelvan D, Moreno V, Gassmann W, Hegenauer J, Saltman P. 1992 Metal ion directed site-specificity of hydroxyl radical detection. Biochim Biophys Acta 1116, 183.
13. Girotti AW. 1990 Photodynamic lipid peroxidation in biological systems. Photochem Photobiol 51, 497.
14. Halliwell B, Gutteridge JMC. 1989 Free Radicals in Biology and Medicine. New York: Oxford University Press; 36.
15. Helman R, Lawrence GD. 1989 Increase in ferrioxamine B reduction potential with increasing acidity of the medium. J Electroanal Chem 276, 187.
16. Hicks M, Gebicki JM. 1986 Rate constants for reaction of hydroxyl radicals with tris, tricine and hepes buffers. FEBS Lett 199, 92.
17. Higgs GA, Salmon JA, Henderson B, Vane JR. 1987 Pharmacokinetics of aspirin and salcylates in relation to inhibition of arachidonate cyclooxygenase and anti-inflammatory action. Proc Natl Acad Sci USA 84, 1417.
18. Koppenol WH. 1987 Thermodynamics of reaction involving oxyradicals and hydrogen peroxide. Bioelectrochemistry and Bioenergetics 18, 3, a section of J Electroanal Chem 232.
19. Kotrlý S, Šucha L. 1985 Handbook of Chemical Equilibria in Analytical Chemistry. Chichester: Ellis Horwood; 163.
20. Letendre ED. 1985 The importance of iron in the pathogenesis of infection and neoplasia. Trends Biochem Sci 10, 166.
21. Lewis GP. 1986 Mediators of Inflammation. Bristol: IOP Publishing; 133.
22. Oberley TD, Oberley LW. 1993. Oxygen radicals and cancer. In: Yu BP, ed. Free Radicals in Aging. Boca Raton, FL: CRC Press; 247-267.
23. Reif DW, Schubert JS, Aust SD. 1988 Iron release from ferritin and lipid peroxidation by radiolytically generated reducing radicals. Arch Biochem Biophys 264, 238.
24. Rodriguez M, Kodadek T, Torres M, Bard AJ. 1990 Cleavage of DNA by electrochemically activated manganese(Il) and iron(III) complexes of meso-tetrakis(N-methyl-4-pyridiniumyl) porphine. Bioconjugate Chem 1, 123.
25. Sedgwick AD, Blake DR, Winwood P, Moore AR, Al Duaij A, Willoughby DA. 1984 Studies into the effects of the iron chelator desferrioxamine on the inflammatory process. Eur J Rheumatol Inflamm 7, 87.
26. Vane JR. 1971 Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231, 232.
27. Wallace DC. 1992 Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 256, 628.
28. Weissmann G. 1991 Aspirin. Sci Am January, 84.
29. Winterbourn C. 1991 Free radical biology of iron. In: Dreosti IE, ed. Trace Elements, Micronutrients and Free Radicals. Totowa, NJ: Humana Press; 53-76.
30. Woollard AC, Wolff SP, Bascal ZA. 1990. Antioxidant characteristics of some potential anticataract agents. Free Rad Biol Med9, 299.
31. Zhao CP, Galazka M, Cheng IF. 1994 Electrocatalytic reduction of hydrogen peroxide by iron adenosine nucleotide complexes. J Electroanal Chem 379, 501.